For research use only. Not for therapeutic Use.
Sodium diatrizoate（Cat No.:I020437）is a contrast agent used in medical imaging, particularly in X-ray and computed tomography (CT) scans. It belongs to the class of iodinated radiopaque compounds, which help improve the visibility of internal structures during imaging procedures. By absorbing X-rays, sodium diatrizoate enhances the contrast of blood vessels, organs, and tissues, aiding in the diagnosis of conditions like arterial blockages, tumors, and abnormalities in organs such as the brain and heart. While generally safe, it can cause allergic reactions or renal issues in some patients, so proper screening is recommended.
| Catalog Number | I020437 |
| CAS Number | 737-31-5 |
| Molecular Formula | C₁₁H₈I₃N₂NaO₄ |
| Purity | ≥95% |
| Target | Apoptosis |
| IUPAC Name | sodium;3,5-diacetamido-2,4,6-triiodobenzoate |
| InChI | InChI=1S/C11H9I3N2O4.Na/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18;/h1-2H3,(H,15,17)(H,16,18)(H,19,20);/q;+1/p-1 |
| InChIKey | ZEYOIOAKZLALAP-UHFFFAOYSA-M |
| SMILES | CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+] |
| Reference | [1]. El-Gendy N, et al. Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent. Int J Pharm. 2010 May 31;391(1-2):305-12.<br>[2]. Dakota B Ward, et al. Radiocontrast Agent Diatrizoic Acid Induces Mitophagy and Oxidative Stress via Calcium Dysregulation. Int J Mol Sci. 2019 Aug 21;20(17):4074. |
